Stephen Fortmann to Tobacco Use Disorder
This is a "connection" page, showing publications Stephen Fortmann has written about Tobacco Use Disorder.
Connection Strength
0.482
-
Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. Nicotine Tob Res. 2015 Sep; 17(9):1126-33.
Score: 0.123
-
Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr; 156B(3):275-84.
Score: 0.094
-
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy. Addiction. 2010 Sep; 105(9):1660-8.
Score: 0.091
-
Generalizability of findings from a chewing tobacco cessation clinical trial. Nicotine Tob Res. 2001 Nov; 3(4):347-52.
Score: 0.049
-
Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psychol. 2000 Oct; 68(5):883-9.
Score: 0.046
-
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med. 1999 Feb; 28(2):113-8.
Score: 0.041
-
Mediated smoking cessation programs in the Stanford Five-City Project. Addict Behav. 1985; 10(4):441-3.
Score: 0.015
-
Onset of major depression during treatment for nicotine dependence. Addict Behav. 2003 Apr; 28(3):461-70.
Score: 0.014
-
Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA. 1988 Sep 16; 260(11):1581-5.
Score: 0.005
-
Health behavior change at the worksite: cardiovascular risk reduction. Prog Behav Modif. 1986; 20:161-97.
Score: 0.004